Concentration Lowered in Tamiflu Medication
When influenza season arrives this fall, a liquid form of Tamifluthe most widely used antiviral flu medicationwill be available in a new, lower concentration to reduce the possibility of medication errors, according to an announcement today by the Food and Drug Administration (FDA).
The change applies to the oral suspension form of Tamiflu. Oral suspension is a powder form of the prescription medication that a pharmacist mixes with water to make a liquid treatment easier to take by children or adults who are unable to swallow a Tamiflu capsule.
The Tamiflu packaging of its oral suspension product says "new strength," meaning that the concentration of medicine in the liquid has been changed from 12 mg/mL (milligrams per milliliter) to 6 mg/mL. It was changed because the higher concentration medication became frothy when mixed, making it difficult to measure the correct dose.
Learn more about this change in one form of this popular flu medication at:
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm262710.htm
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.
